Attovia Therapeutics, Inc.
(ATTO - NASDAQ)
25,55 USD
📋 Profilo Aziendale

A clinical-stage biopharmaceutical company developing biotherapeutics for immune-mediated diseases using its ATTOBODY biologics platform.

|